Guest guest Posted July 10, 2009 Report Share Posted July 10, 2009 All, Attached is a draft of a review of the FDA's 'Thimerosal in Vaccines Questions and Answers' webpage. This document provides answers to the numerous obvious misrepresentations made by the FDA in a doublespeak- filled webpage that asks the wrong questions and then fals to provide truthful answers to even its biased questions. Unfortunately, the document is too long and complex for me to provide you a rough text of it. If you get this e-mail but not the attachment, after the middle of the month, you can download it in " pdf " form from the CoMeD website: http://www.mercury-freedrugs.com. or, if your need is more immediate, please send me a request for it at: paulgkingphd@... This copyrighted (by the author) document is being freely distrubuted with the understanding that any recipient agrees that he or she will not publish any portion of it out of its context and that he or she will credit the author, G. King, PhD, and the authoring organization, CoMeD, Inc. Please feel free to distribute this document to your friends. Also, PLEASE send a copy to each of your U.S. Senators and your U.S. Congressman requesting that he or she pursue the apparent " Data Quality Act " violations in the FDA's original document quoted w/o alteration, EXCEPT as noted, in the text of this review and available at: Hopefully, this review will help anyone who carefully reads it to understand just how broken the FDA is when it comes to, as the 2003 Congressional report 'Mercury In Medicine -- Taking Unnecessary Risks' found: a. The failure of the manufacturers of Thimerosal- preserved vaccines to comply with the recipient safety requirement that each dose of a Thimerosal-preserved vaccine MUST be proven by the applicant/sponsor/manufacturer to be " sufficiently nontoxic ... " , something that ONLY toxicity studies can do, BEFORE filing for a license for that Thimerosal-preserved vaccine (21 CFR 620.15(a)), b. The failure of the applicant/sponsor/manufac- ture MUST submit that proof of safety in its license application (21 CFR 601.2(a)), and c. The FDA's failure to: 1. Enforce the law governing preservative toxicity testing (21 CFR 610.15(a)), 2. Comply with the laws governing the FDA's conduct (21 CFR 601.4(a)) when it comes to the licensing of any vaccine including a Thimerosal-preserved vaccine when the makers thereof have failed to provide proof that their Thimerosal- preserved vaccines are " sufficiently nontoxic ... " , a requirement from 1973 onwards, and 3. Protect all those people involved from the first clinical onwards from being UNNECESSARILY subacutely mercury-poisoned by the Thimerosal, a known human teratogen, mutagen, carcinogen and immune-system disruptor at dose-levels below 1 ppm, in the Thimerosal-preserved vaccines where the manufacture of the vaccine have NOT proven, and NOT been required to prove the toxicological safety of the Thimerosal being used as a preservative to the standard " sufficiently nontoxic ... " BEFORE any human can be injected with that Thimerosal-preserved vaccine. Respectfully, Dr. King http://www.dr-king.com ++++++++++++++++++++++++++++++++++++++++++++++++++++++ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.